UBC Buys Biostatistical and Medical Writing Firm BioCor
Maryland-based clinical trial design, and data management and consulting company United BioSource Corporation (UBC) has acquired BioCor LLC, a biostatistical, data services and medical writing firm based in Yardley, Pa. One of BioCor's specialties is designing trial protocols with advanced biostatistical methods for emerging biotech companies. It will be the first business unit in what is to become UBC's Biotechnology Solutions Group.
UK Aims to Speed up Trials with One-Stop NHS Review Process
Hospitals within the UK's National Healthcare System (NHS) can now benefit from a revision of the country's Model Clinical Trial Agreement rules, which include the trial site review process. Under the new system, only one review would be necessary for industry-sponsored trials taking place within the NHS network, where previously each site required individual clearance. The study must get approval from the Medicines and Healthcare products Regulatory Agency (MHRA) before the review process can begin.
Other breaking news...
Qualia in strategic alliance with Tandem Labs...
eResearch Technology reports lower than expected third quarter earnings...
Company Profile: An interview with Jordi Naval, managing director, Infociencia.
To read the full articles for this issue or for more information on these and other breaking stories, please click here!
